New option available for Alzheimer’s patients as FDA approves expanded drug use
Top Story
•
May 12, 2026
•
0 Views
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
Source: https://feeds.feedburner.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
